News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3129last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Simply Wall St.113d agoneutral
Philip Morris International (PM) Is Up 6.3% After FDA Grants ZYN Modified Risk Status - Has The Bull Case Changed?Simply Wall St.114d agoneutral
Is Philip Morris International (PM) Fully Valued On ZYN FDA Authorization?Motley Fool122d agoneutral
Want a Lifetime of Passive Income? Buy Altria Stock in July and Never Sell.Barrons.com129d agoneutral
Philip Morris’ Safer Products Are Winning With Regulators. They’ll Win With Investors Too.Simply Wall St.129d agobullish
Philip Morris International (PM) Wins First FDA Modified Risk Nod For ZYN PouchesBarrons.com131d agoneutral
Zyn’s New ‘Lower Risk’ Label Could Give It an Edge Over Rival Nicotine PouchesInvesting.com131d agoneutral
FDA clears PM’s Zyn to market as lower cancer risk than cigarettes in 20 variantsThe Wall Street Journal131d agoneutral
Zyn Can Be Marketed as Safe Alternative to Cigarettes, FDA SaysMotley Fool131d agobullish
Altria vs. Philip Morris International: Which Consumer Goods Stock Is a Better Buy in 2026?MT Newswires135d agoneutral
Philip Morris, Other Tobacco Stocks Rise After FDA Proposes Foreign Tobacco RegulationsInsider Monkey135d agoneutral
Morgan Stanley and Stifel Raise Confidence in Philip Morris (PM) Ahead of ZYN Ultra Launch and IQOS ExpansionSimply Wall St.138d agoneutral
Philip Morris International (PM) Stock After 11.5% YTD Gain Are Valuation Concerns JustifiedSimply Wall St.138d agoneutral
What Philip Morris International (PM)'s EU Advocacy and Dividend Reaffirmation Means For Shareholders